Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2022年9月29日
	新闻
	Scientists have uncovered how air pollution causes lung cancer The World Economic Forum Scientists in the UK say they have proven a link between tiny particulates in polluted air and lung cancer cases. They have also discovered a molecule ... 标记为不相关
	Incidental sinoatrial node irradiation may increase AF risk in lung cancer Medicine Matters oncology medwireNews: Incidental irradiation of the sinoatrial node (SAN) during lung cancer chemoradiotherapy may be associated with an increased risk for ... 标记为不相关
	Adjuvant pembrolizumab increased disease-free survival in completely resected, PD-L1 ... 2 Minute Medicine 1. Adjuvant pembrolizumab significantly improved disease-free survival in comparison to placebo in PD-L1 unselected non-small-cell lung cancer ... 标记为不相关
	Health Tips Tuesday: lung cancer symptoms - Western Mass News Western Mass News The American Cancer Society reports that lung cancer is the leading cause of cancer death making up almost a quarter of all cancer deaths. 标记为不相关
	Treatment Options for Early-Stage Non-Small Cell Lung Cancer (NSCLC) - OncLive OncLive Melissa Johnson, MD, and Solange Peters, MD, review the available treatment options for stage I – III non-small cell lung cancer (NSCLC) and how ... 标记为不相关
	Self-Reported Lung-Related Comorbidities Do Not Impact Lung Cancer Screening Outcomes Cancer Therapy Advisor Researchers sought to determine if self-reported lung-related comorbidities are an indicator of poor outcomes on lung cancer screening. 标记为不相关
	Circadian disruption enhances HSF1 signaling and tumorigenesis in Kras-driven lung cancer Science Molecular characterization of tumors and tumor-bearing lung tissues revealed that CJL enhances the expression of heat shock factor 1 (HSF1) target ... 标记为不相关
	Adagrasib in Non–Small-Cell Lung Cancer | NEJM New England Journal of Medicine (July 14 issue)1 report the results of a phase 2 study of adagrasib involving patients with KRASG12C-mutated non–small-cell lung cancer (NSCLC). 标记为不相关
	FDA Approves Avastin Biosimilar to Treat Six Diseases Including Certain Colon, Lung ... Cure Today The Food and Drug Administration (FDA) approved the biosimilar Vegzelma (bevacizumab-adcd) for the treatment of six cancer types including ... 标记为不相关
	FDA Approves Oncomine DX Target Test as Companion Diagnostic for RET+ Thyroid ... Cancer Network ... granted approval by the FDA as a companion diagnostic for RET fusion–positive thyroid cancer and RET fusion–positive non–small cell lung cancer. 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈